ERBB2 and breast cancer: Similar to the T47D and MCF7 luminal cell lines, we next wanted to determine if the therapeutic ERBB2-binding antibodies could induce phosphorylation of the ERBB-receptors in these cell lines of other breast cancer subtypes as well.